Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records

View ORCID ProfileJemma L Walker, View ORCID ProfileDaniel J Grint, View ORCID ProfileHelen Strongman, View ORCID ProfileRosalind M Eggo, View ORCID ProfileMaria Peppa, View ORCID ProfileCaroline Minassian, View ORCID ProfileKathryn E Mansfield, View ORCID ProfileChristopher T. Rentsch, Ian J Douglas, View ORCID ProfileRohini Mathur, Angel Wong, View ORCID ProfileJennifer K Quint, Nick Andrews, Jamie Lopez Bernal, J Anthony Scott, Mary Ramsay, View ORCID ProfileLiam Smeeth, View ORCID ProfileHelen I McDonald
doi: https://doi.org/10.1101/2020.08.24.20179192
Jemma L Walker
1 London School of Hygiene & Tropical Medicine, Public Health England;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jemma L Walker
  • For correspondence: jemma.walker@lshtm.ac.uk
Daniel J Grint
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel J Grint
  • For correspondence: daniel.grint@lshtm.ac.uk
Helen Strongman
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen Strongman
  • For correspondence: helen.strongman@lshtm.ac.uk
Rosalind M Eggo
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rosalind M Eggo
  • For correspondence: r.eggo@lshtm.ac.uk
Maria Peppa
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Peppa
  • For correspondence: m.peppa@ucl.ac.uk
Caroline Minassian
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caroline Minassian
  • For correspondence: caroline.minassian@lshtm.ac.uk
Kathryn E Mansfield
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathryn E Mansfield
  • For correspondence: kathryn.mansfield@lshtm.ac.uk
Christopher T. Rentsch
3 US Department of Veterans Affairs, London School of Hygiene and Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher T. Rentsch
  • For correspondence: christopher.rentsch@lshtm.ac.uk
Ian J Douglas
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ian.douglas@lshtm.ac.uk
Rohini Mathur
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rohini Mathur
  • For correspondence: rohini.mathur@lshtm.ac.uk
Angel Wong
4 London School of Hygiene and Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: angel.wong@lshtm.ac.uk
Jennifer K Quint
5 Imperial College London;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennifer K Quint
  • For correspondence: j.quint@imperial.ac.uk
Nick Andrews
6 Public Health England;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nick.andrews@phe.gov.uk
Jamie Lopez Bernal
6 Public Health England;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jamie.lopezbernal2@phe.gov.uk
J Anthony Scott
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anthony.scott@lshtm.ac.uk
Mary Ramsay
6 Public Health England;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mary.ramsay@phe.gov.uk
Liam Smeeth
2 London School of Hygiene & Tropical Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Liam Smeeth
  • For correspondence: liam.smeeth@lshtm.ac.uk
Helen I McDonald
7 London School of Medicine and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen I McDonald
  • For correspondence: helen.mcdonald@lshtm.ac.uk
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background This study aimed to describe the population at risk of severe COVID-19 due to underlying health conditions across the United Kingdom in 2019. Methods We used anonymised electronic health records from the Clinical Practice Research Datalink GOLD to describe the point prevalence on 5 March 2019 of the at-risk population following national guidance. Prevalence for any risk condition and for each individual condition is given overall and stratified by age and region. We repeated the analysis on 5 March 2014 for full regional representation and to describe prevalence of underlying health conditions in pregnancy. We additionally described the population of cancer survivors, and assessed the value of linked secondary care records for ascertaining COVID-19 at-risk status. Findings On 5 March 2019, 24.4% of the UK population were at risk due to a record of at least one underlying health condition, including 8.3% of school-aged children, 19.6% of working-aged adults, and 66.2% of individuals aged 70 years or more. 7.1% of the population had multimorbidity. The size of the at-risk population was stable over time comparing 2014 to 2019, despite increases in chronic liver disease and diabetes and decreases in chronic kidney disease and current asthma. Separately, 1.6% of the population had a new diagnosis of cancer in the past five years. Interpretation The population at risk of severe COVID-19 (aged ≥70 years, or with an underlying health condition) comprises 18.5 million individuals in the UK, including a considerable proportion of school-aged and working-aged individuals.

Competing Interest Statement

The study was funded by the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE). JLW, DJG, NA, JAS, LS, HM received grants from the NIHR HPRU in Immunisation to support the submitted work. RME received grants from HDR UK (MR/S003975/1) and UK MRC (MC_PC 19065). JKQ reports grants and personal fees from AZ, grants from Asthma UK, grants and personal fees from BI, grants and personal fees from Bayer, grants and personal fees from Insmed, grants and personal fees from GSK, grants from The Health Foundation , grants from MRC, grants from British Lung Foundation, outside the submitted work; RM reports personal fees from AMGEN, outside the submitted work; JAS reports grants from National Institute for Health Research, during the conduct of the study; grants from MRC, grants from Wellcome Trust, grants from GAVI The Vaccine Alliance, grants from Bill & Melinda Gates Foundation, outside the submitted work; LS reports grants from Wellcome, grants from MRC, grants from NIHR, grants from GSK, grants from BHF, grants from Diabetes UK, outside the submitted work; and Is a Trustee of the British Heart Foundation. The PHE Immunisation and Countermeasures Department provides vaccine manufacturers with post-marketing surveillance reports which the companies are required to submit to the UK Licensing authority in compliance with their Risk Management Strategy. A cost recovery charge is made for these reports. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care, or PHE.

Clinical Trial

This is not a clinical trial.

Funding Statement

The study was funded by the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE). JLW, DJG, NA, JAS, LS, MR and HM received grants from the NIHR HPRU in Immunisation to support the submitted work. RME received grants from HDR UK (MR/S003975/1) and UK MRC (MC_PC 19065). The study funder had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; nor in the decision to submit the paper for publication. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care, or PHE.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approval was received from the Independent Scientific Advisory Committee of the Medicines and Healthcare Products Regulatory Agency (ISAC number: 20_062A) and the Ethics Committee of the London School of Hygiene and Tropical Medicine (reference 21851).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data used for this study were obtained from the Clinical Practice Research Datalink (CPRD). All CPRD data are available via an application to the Independent Scientific Advisory Committee (see https://www.cprd.com/Data-access). Data acquisition is associated with a fee and data protection requirements. This manuscript is supported by shared codelists used to define each condition, and full estimates of the prevalence of the at-risk population and each underlying health condition, stratified by age and region (separately and combined) are provided online.

https://doi.org/10.17037/DATA.00001833

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 26, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records
Jemma L Walker, Daniel J Grint, Helen Strongman, Rosalind M Eggo, Maria Peppa, Caroline Minassian, Kathryn E Mansfield, Christopher T. Rentsch, Ian J Douglas, Rohini Mathur, Angel Wong, Jennifer K Quint, Nick Andrews, Jamie Lopez Bernal, J Anthony Scott, Mary Ramsay, Liam Smeeth, Helen I McDonald
medRxiv 2020.08.24.20179192; doi: https://doi.org/10.1101/2020.08.24.20179192
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records
Jemma L Walker, Daniel J Grint, Helen Strongman, Rosalind M Eggo, Maria Peppa, Caroline Minassian, Kathryn E Mansfield, Christopher T. Rentsch, Ian J Douglas, Rohini Mathur, Angel Wong, Jennifer K Quint, Nick Andrews, Jamie Lopez Bernal, J Anthony Scott, Mary Ramsay, Liam Smeeth, Helen I McDonald
medRxiv 2020.08.24.20179192; doi: https://doi.org/10.1101/2020.08.24.20179192

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (411)
  • Dentistry and Oral Medicine (68)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4839)
  • Forensic Medicine (3)
  • Gastroenterology (180)
  • Genetic and Genomic Medicine (674)
  • Geriatric Medicine (70)
  • Health Economics (191)
  • Health Informatics (624)
  • Health Policy (318)
  • Health Systems and Quality Improvement (203)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5312)
  • Intensive Care and Critical Care Medicine (328)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (684)
  • Nursing (42)
  • Nutrition (113)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (204)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (128)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (777)
  • Public and Global Health (1808)
  • Radiology and Imaging (323)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)